Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Manders Insider Profile
4 Followers
Matthew Manders, Pres, Government and Solutions at Cigna, holds 6.24K shares in NeueHealth Inc (Ticker: NEUE), holds 43.49K shares in Cigna (Ticker: CI).
Matthew Manders has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Manders holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Manders
Matthew Manders's Trading History
Cigna
Nov 23, 2021
Pres, Government and Solutions
Uninformative Sell
230.96K
$14.61M
NeueHealth Inc
May 14, 2024
Director
Uninformative Buy
29.29K
$32.70K
List of latest transactions for each holding click on a transaction to see Matthew Manders's performance on stock
You May Also Like
Matthew Manders insider profile FAQ
What is the percentage of profitable transactions made by Matthew Manders?
The percentage of profitable transactions made by Matthew Manders is ―.
What is the average return per transaction made by Matthew Manders?
The average return per transaction made by Matthew Manders is ―.
What stocks does Matthew Manders hold?
Matthew Manders holds: CI, NEUE stocks.
What was Matthew Manders’s latest transaction?
Matthew Manders latest transaction was an Uninformative Buy of $29.29K.
What was Matthew Manders's most profitable transaction?
Matthew Manders’s most profitable transaction was an Informative Sell of CI stock on March 7, 2013. The return on the trade was -34.20%.
What is Matthew Manders's role in Cigna?
Matthew Manders's role in Cigna is Pres, Government and Solutions.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.